PortfoliosLab logoPortfoliosLab logo
Inspire Medical Systems, Inc. (INSP)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US4577301090
CUSIP
457730109
IPO Date
May 3, 2018

Highlights

Market Cap
$1.51B
Enterprise Value
$1.43B
EPS (TTM)
$4.94
PE Ratio
10.44
PEG Ratio
0.06
Total Revenue (TTM)
$911.98M
Gross Profit (TTM)
$778.76M
EBITDA (TTM)
$66.00M
Year Range
$48.30 - $163.35
Target Price
$106.58
ROA (TTM)
16.03%
ROE (TTM)
18.62%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Inspire Medical Systems, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Inspire Medical Systems, Inc. (INSP) has returned -44.07% so far this year and -67.62% over the past 12 months.


Inspire Medical Systems, Inc.

1D
2.32%
1M
-20.04%
YTD
-44.07%
6M
-30.49%
1Y
-67.62%
3Y*
-39.60%
5Y*
-24.33%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 3, 2018, INSP's average daily return is +0.11%, while the average monthly return is +2.19%. At this rate, your investment would double in approximately 2.7 years.

Historically, 54% of months were positive and 46% were negative. The best month was Nov 2025 with a return of +72.6%, while the worst month was May 2024 at -34.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, INSP closed higher 51% of trading days. The best single day was Nov 3, 2020 with a return of +31.8%, while the worst single day was May 8, 2024 at -33.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-17.84%-14.87%-20.04%-44.07%
20254.38%-4.09%-14.18%-0.57%-12.74%-6.10%-4.03%-24.77%-20.80%-2.86%72.60%-25.87%-50.25%
20243.66%-15.09%19.97%12.51%-34.29%-15.72%5.39%27.49%17.37%-7.59%-1.17%-3.83%-8.87%
20230.47%2.71%-9.95%14.34%9.29%10.99%-11.34%-21.17%-12.54%-25.84%-1.26%40.00%-19.24%
2022-3.81%10.29%5.17%-19.84%-14.06%3.30%14.41%-8.37%-7.37%9.91%23.91%4.27%9.48%
20217.13%15.52%-11.08%14.41%-17.95%-0.54%-5.23%22.06%4.17%15.76%-17.18%3.04%22.31%

Benchmark Metrics

Inspire Medical Systems, Inc. has an annualized alpha of 10.91%, beta of 1.30, and R² of 0.18 versus S&P 500 Index. Calculated based on daily prices since May 04, 2018.

  • This stock participated in 131.41% of S&P 500 Index downside but only 126.75% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.18 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
10.91%
Beta
1.30
0.18
Upside Capture
126.75%
Downside Capture
131.41%

Return for Risk

Risk / Return Rank

INSP ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


INSP Risk / Return Rank: 55
Overall Rank
INSP Sharpe Ratio Rank: 55
Sharpe Ratio Rank
INSP Sortino Ratio Rank: 55
Sortino Ratio Rank
INSP Omega Ratio Rank: 44
Omega Ratio Rank
INSP Calmar Ratio Rank: 33
Calmar Ratio Rank
INSP Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and compare them to a chosen benchmark (S&P 500 Index).


INSPBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.92

0.90

-1.82

Sortino ratio

Return per unit of downside risk

-1.54

1.39

-2.92

Omega ratio

Gain probability vs. loss probability

0.78

1.21

-0.43

Calmar ratio

Return relative to maximum drawdown

-0.97

1.40

-2.37

Martin ratio

Return relative to average drawdown

-1.62

6.61

-8.23

Explore INSP risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Inspire Medical Systems, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Inspire Medical Systems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inspire Medical Systems, Inc. was 84.63%, occurring on Mar 27, 2026. The portfolio has not yet recovered.

The current Inspire Medical Systems, Inc. drawdown is 84.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.63%Jul 17, 2023678Mar 27, 2026
-53.71%Mar 3, 202015Mar 23, 202060Jun 17, 202075
-47.34%Nov 9, 2021125May 9, 2022250May 8, 2023375
-34.95%Sep 5, 201866Dec 7, 201842Feb 8, 2019108
-33.83%Mar 2, 202167Jun 4, 202173Sep 17, 2021140

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Inspire Medical Systems, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Inspire Medical Systems, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for INSP, comparing it with other companies in the Medical Devices industry. Currently, INSP has a P/E ratio of 10.4. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for INSP compared to other companies in the Medical Devices industry. INSP currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for INSP relative to other companies in the Medical Devices industry. Currently, INSP has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for INSP in comparison with other companies in the Medical Devices industry. Currently, INSP has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items